Overview

Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 Diabetes

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to demonstrate the immediate impact of pantoprazole on 24-H glycemic control and on post-prandial glucose excursion in patients with type 2 diabetes.If our data support the previous animal, observational and clinical studies results, PPIs could become a new anti-diabetic agent with a good and safe profile for type 2 diabetes
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Dr. Waheed Rehman
Treatments:
Pantoprazole
Criteria
Inclusion Criteria: Type 2 Diabetes with HbA1C > 8% -

Exclusion Criteria: Type diabetics 1 and 2 on insulin

-